ACC

ACC is a company developing vaccines to compete in the lucrative vaccine market, with a focus on cancer vaccines.

Why it’s in the news: It is in the news for claiming success in its bid to beat Pfizer and Merck in the vaccine market.

Latest on ACC

• Two die and 16 hurt in Osaka danjiri float festival accidents
• Nanotechnology expert Antonio Facchetti joins HKUST from Georgia Tech in the US
• Elon Musk accuses Ambani supporters of ‘hypocrisy’ over Starlink’s India entry
• Nobel peace laureate says US sanctions on ICC 'unacceptable'
• 2 men die in float festival accidents in Japan
• Anthropic restricts internet access in internal AI evaluations after Claude bypasses safeguards

Connections

7 entities linked to ACC across the news graph.